Similar articles

• Rationales for vaccines against leprosy.

  Bloom BR. Bloom BR. Int J Lepr Other Mycobact Dis. 1983 Dec;51(4):505-9. Int J Lepr Other Mycobact Dis. 1983. PMID: 6368414 Clinical Trial. No abstract available.
• Progress in the preparation of an antileprosy vaccine from armadillo-derived Mycobacterium leprae.

  Rees RJ. Rees RJ. Int J Lepr Other Mycobact Dis. 1983 Dec;51(4):515-8. Int J Lepr Other Mycobact Dis. 1983. PMID: 6368415 No abstract available.
• Under-explored experimental topics related to integral mycobacterial vaccines for leprosy.

  Gormus BJ, Meyers WM. Gormus BJ, et al. Expert Rev Vaccines. 2003 Dec;2(6):791-804. doi: 10.1586/14760584.2.6.791. Expert Rev Vaccines. 2003. PMID: 14711362 Review.
• Antileprosy protective vaccination of sooty mangabey monkeys with BCG or BCG plus heat-killed Mycobacterium leprae: immunologic observations.

  Gormus BJ, Baskin GB, Xu K, Ratterree MS, Martin LN, Mack PA, Bohm RP Jr, Meyers WM, Walsh GP. Gormus BJ, et al. Int J Lepr Other Mycobact Dis. 2000 Dec;68(4):434-43. Int J Lepr Other Mycobact Dis. 2000. PMID: 11332286
• A strategy to improve the efficacy of vaccination against tuberculosis and leprosy.

  Bretscher PA. Bretscher PA. Immunol Today. 1992 Sep;13(9):342-5. doi: 10.1016/0167-5699(92)90168-7. Immunol Today. 1992. PMID: 1466750 Review.